Bank of America’s Senti Biosciences Holdings SNTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75
Closed -$78 6744
2025
Q4
$78 Sell
75
-375
-83% -$663 ﹤0.01% 6871
2025
Q3
$634 Sell
450
-107
-19% -$179 ﹤0.01% 7552
2025
Q2
$1.18K Buy
557
+431
+342% +$1.36K ﹤0.01% 7504
2025
Q1
$423 Buy
126
+6
+5% +$23 ﹤0.01% 7544
2024
Q4
$421 Sell
120
-231
-66% -$737 ﹤0.01% 7440
2024
Q3
$793 Buy
351
+269
+328% +$711 ﹤0.01% 7294
2024
Q2
$227 Buy
82
+58
+242% +$188 ﹤0.01% 7534
2024
Q1
$91 Sell
24
-500
-95% -$2.23K ﹤0.01% 7407
2023
Q4
$3.46K Sell
524
-2,644
-83% -$10.3K ﹤0.01% 7060
2023
Q3
$13.1K Buy
3,168
+3,147
+14,986% +$21.7K ﹤0.01% 6800
2023
Q2
$133 Buy
+21
New +$205 ﹤0.01% 7405
2023
Q1
Sell
-2
Closed -$28 8235
2022
Q4
$28 Sell
2
-1,430
-100% -$34.9K ﹤0.01% 7919
2022
Q3
$31K Buy
1,432
+1
+0.1% +$20 ﹤0.01% 6866
2022
Q2
$28K Buy
+1,431
New +$115K ﹤0.01% 7074
2021
Q3
Sell
-143
Closed -$14K 8368
2021
Q2
$14K Buy
+143
New +$14.3K ﹤0.01% 7233

Other funds holding SNTI

Bank of America's SNTI Position: Q1 2026 in Review

Bank of America sold out of Senti Biosciences Holdings (SNTI) in Q1 2026, closing a stake of 75 shares — an estimated $78 sold.

Bank of America first reported a position in SNTI in Q2 2021 and held it in 15 quarters. The position peaked at $31K in Q3 2022. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.

  • Bank of America reported no remaining Senti Biosciences Holdings position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 75 Senti Biosciences Holdings shares in Q1 2026, an estimated $78.
  • Bank of America first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 15 quarters.
  • Bank of America's Senti Biosciences Holdings position peaked at $31K in Q3 2022.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.